Spoiler alert: your fitness tracker was lying to you all along..
For years, the connected devices industry has been selling us the famous target of 10,000 steps a day. A round figure, easy to remember, perfect for marketing... but totally devoid of any rigorous scientific basis. A major meta-analysis published in The Lancet Public Health has just set the record straight with a conclusion that will make people cringe: 7,000 steps a day is more than enough to achieve most of the health benefits. Just like when you discover that a functional ingredient at 500mg provides the same effects as at 1000mg - sometimes less really is more.
How many steps a day for good health: 57 studies scrutinised
Precision engineering behind the numbers
Ding Ding's team (University of Sydney) has deployed the heavy artillery of clinical research: 57 prospective studies from 35 cohorts, over 160,000 participants followed over several years. To grasp the scale of the problem, imagine simultaneously analysing all the clinical trials on the efficacy of probiotics in the last 10 years ...
Methodology? From non-linear dose-response analyses with modelling using restricted cubic splines. In short: the researchers have mathematically dissected each level of activity to identify the true thresholds of efficacy, like a formulator optimising the bioavailability of a nutrient.
Inflection points: where the magic happens
The curves reveal inflection points between 5000 and 7000 paces for the majority of health benefits. What does this mean in practice? Above these thresholds, each additional step brings diminishing marginal benefits - exactly like the saturation curves we see with antioxidants or omega-3s.
This is the difference between optimising a formulation and over-dosing as a precaution.
Deciphering the benefits: solid, measurable, concrete
All-cause mortality: -47% less risk, can you refuse?
At 7,000 daily steps (vs. 2,000 reference steps): 47% reduction in mortality risk (HR 0.53; IC 95%: 0.46-0.60). To put this performance into context, it's comparable to the protective effects observed with regular consumption of polyphenols or omega-3 fatty acids - but with zero investment in supplements.
The inflection occurs at 5391 not precisely.
Cardiovascular system: double dividend proven
The cardiovascular benefits follow a fascinating dose-response logic:
Primary prevention (incidence) :
- 25% reduction in risk at 7000 steps (HR 0.75; CI 95%: 0.67-0.85)
- Inflection point at 7802 steps
Secondary prevention (mortality) :
- 47% reduction in risk (HR 0.53; CI 95%: 0.37-0.77)
- Earlier inflection point at 5422 paces
This dichotomy suggests distinct physiological mechanisms Walking is thought to have a different effect on the prevention of initial events versus their severity. A bit like certain functional ingredients that target chronic inflammation AND the acute inflammatory response via different metabolic pathways.
Cancer: encouraging signs, but they need to be qualified
The oncological results deserve a closer look:
- Cancer mortality -37% at 7000 steps (significant)
- Incidence of cancer -6% only (not significant)
This asymmetry raises questions: does walking have a greater influence on the tumour progression than cancer initiation? A plausible hypothesis, given the effects of exercise on immunity, inflammation and cellular energy metabolism.
Strategic analysis: implications for the healthcare ecosystem
For the nutraceuticals industry: repositioning claims
This study reshuffles the deck in the science marketing. Manufacturers of «performance» and «endurance» ingredients can now calibrate their claims to scientifically validated activity thresholds.
Concrete opportunity : develop formulations specifically dosed to support the «7000 steps» objective, rather than targeting intensive sportsmen and women. Think magnesium, CoQ10 or adaptogens for daily endurance.
Connected objects: recalibration needed
Tracker manufacturers will have to review their motivation algorithms. Setting a default target of 7,000 steps instead of 10,000 could paradoxically improve user adherence - and therefore customer retention.
A perfect analogy: when supplement brands stopped promising unrealistic results and focused instead on achievable benefits, their customer satisfaction rates soared.
Methodological limitations: keeping a critical eye
Geographical and technological biases
Major point of attention : 37% of the studies come from the United States, with a glaring under-representation of low/middle-income countries. In the food industry, we know that a formulation validated in the West does not necessarily apply to populations with different nutritional profiles.
Instrumental heterogeneity : 77% accelerometers versus 19% pedometers. Like comparing the efficacy of an active ingredient measured by HPLC versus spectrophotometry - technically valid, but with nuances of precision.
The pitfall of one-off measurements
Assessing physical activity over a few days to predict outcomes over 5-10 years? It's the equivalent of a 24-hour dietary recall to assess long-term nutritional status. Methodologically questionable, even if statistically significant.
Demographic stratification: personalisation is key
Young adults vs. seniors: two different approaches
The analysis reveals age-dependent patterns crucial :
Under 65 :
- Non-linear curve with inflection at 5410 steps
- Observable efficiency plateau
Over 65s :
- Linear relationship with no apparent plateau
- Proportional benefits up to high levels
Practical implications : generic one-size-fits-all recommendations are showing their limitations. The nutraceutical industry has long understood this with specific life-stage formulations (children, adults, seniors).
Device-agnostic benefits: democratising access
Excellent news: no significant difference between accelerometers and pedometers for its measured health benefits. The message? You don't need the latest €300 gadget to optimise your health - a simple €15 pedometer will do the trick.
Mechanisms of action: why does it work?
The physiology behind the figures
7000 daily steps correspond approximately to :
- 30-40 minutes of moderate activity
- Energy expenditure of 200-300 kcal (according to body weight)
- Activation of cardioprotective metabolic pathways
This dose of exercise triggers a cascade of benefits: improved insulin sensitivity, reduced systemic inflammation, optimised lipid profile.
Towards a redefinition of public health recommendations?
The likely domino effect
This meta-analysis will probably recalibrating public health policies worldwide. More accessible target = better public acceptance = greater epidemiological impact.
Cross-sector opportunities
Players can anticipate strategic partnerships :
- Health insurers × Tracker manufacturers (customised incentives)
- Nutraceutical brands, sports nutrition × Wellness apps (synergistic formulations)
- Employers × Corporate wellness programmes (measured health ROI)
Conclusion: less is more, scientifically proven at last
This meta-analysis confirms an intuition that the nutrition industry is well aware of: optimisation often beats maximisation. 7,000 steps a day offers a remarkable benefit/effort ratio, without the need for state-of-the-art technology.
For health and nutrition professionals, it provides a solid evidence-based foundation on which to develop realistic, scientifically sound recommendations. In the end, perhaps conventional wisdom was wrong: when it comes to physical activity as much as to nutritional formulation, aiming high is better than aiming low.
What if the secret to optimal health simply lay in consistency rather than intensity? This study seems to suggest so.
Source :
Ding, D., Nguyen, B., Nau, T., et al. (2025). Daily steps and health outcomes in adults: a systematic review and dose-response meta-analysis. The Lancet Public Health. DOI: https://doi.org/10.1016/S2468-2667(25)00164-1
Link to the full study: https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(25)00164-1/fulltext